Immunogen (IMGN) Prices Upsized 11.64M Share Offering at $6.60/sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- Tech stocks power S&P 500 to record high as oil prices, producer inflation ease
- Oil pares losses after reports Houthis attacked Saudi Aramco refinery
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Jefferies Upgrades Immunogen Inc. (IMGN) to Buy
December 1, 2021 3:36 AM ESTJefferies analyst Kelly Shi upgraded Immunogen Inc. (NASDAQ: IMGN) from Hold to Buy with a price target of $12.00 (from $7.00).
For an analyst ratings summary and ratings history on Immunogen Inc. click here. For more ratings news on Immunogen Inc. click here.
Shares of Immunogen Inc. closed at $6.45 yesterday.
... MoreImmunogen (IMGN) to Offer $175M in Common Stock
November 30, 2021 4:01 PM ESTImmunoGen Inc. (Nasdaq:... More
Immunogen Inc. (IMGN) PT Raised to $7 at SVB Leerink, Following Clinical Business Update
November 30, 2021 3:23 PM ESTSVB Leerink analyst Jonathan Chang raised the price target on Immunogen Inc. (NASDAQ: IMGN) to $7.00 (from $5.00) while maintaining a Market Perform rating.
... MoreIncreasing unusual option volume: IMGN EWG KRYS CHS CERN VIR EVC BZUN
November 30, 2021 9:53 AM ESTIncreasing unusual option volume: IMGN EWG KRYS CHS CERN VIR EVC BZUN
... MorePre-Open Stock Movers 11/30: (CPIX) (IMGN) (VIR) Higher; (JKS) (LIZI) (SEDG) Lower (more...)
November 30, 2021 9:28 AM ESTPre-Open Movers
Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) 129% HIGHER; announced the U.S. Food and Drug Administration (FDA) has approved expanded labeling for Caldolor®, an intravenously delivered formulation of ibuprofen, to now include use in pre-operative administration. The non-narcotic pain reliever may now be administered just prior to surgery to enable patients to wake up from their procedure in significantly less pain.
ImmunoGen Inc. (Nasdaq: IMGN) 45.5% HIGHER; announced positive top-line data from the pivotal SORAYA trial evaluating the safety and efficacy... More
Immunogen (IMGN) Shares Up 40%, Following Positive SORAYA Trial Results
November 30, 2021 8:10 AM ESTImmunogen (NASDAQ: IMGN) shares are gaining nearly 40% in pre-market on heavy volume, following positive results from the company's SORAYA clinical trial.
Immunogen (IMGN) Announces Positive Top-Line Results from Pivotal SORAYA Trial of Mirvetuximab Soravtansine in Ovarian Cancer
November 30, 2021 6:30 AM ESTImmunoGen Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced positive top-line data from the pivotal SORAYA trial evaluating the safety and efficacy of mirvetuximab soravtansine (mirvetuximab) monotherapy in patients with folate receptor alpha (FR)-high platinum-resistant ovarian cancer who have been previously treated with Avastin® (bevacizumab).
... More
